Back
Neurogene Stock Predictions
Sponsored
NGNE
Sponsored
The dark truth about AI
Click here to learn more...
Sell
18
NGNE
Neurogene
Last Price:
23.31
Seasonality Move:
25.92%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)Neurogene Stock Forecast
- Over the next 52 weeks, Neurogene has on average historically risen by 24.9% based on the past 10 years of stock performance.
- Neurogene has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Neurogene Stock Undervalued?
The current Neurogene [NGNE] share price is $22.34. The Score for NGNE is 18, which is 64% below its historic median score of 50, and infers higher risk than normal. - NGNE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Neurogene Stock Go Up Next Year?
- Over the next 52 weeks, Neurogene has on average historically risen by 24.9% based on the past 10 years of stock performance.
Neurogene Stock Rating
Sell
18
Neurogene (NGNE)
is a Sell
Is Neurogene overpriced?
- Neurogene has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Neurogene Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
neurogene.com
52-Week Data
52-Week High:
74.49
52-Week Low:
12.49
Prediction Charts
Market Cap:
331.78M
Price in USD:
22.34
Volume:
301.86K
Beta:
-1.35
Technical Analysis
SMA50:
40.26
SMA100:
39.25
SMA200:
38.23
52-Wk Change:
69.2%
Stock Predictions
-
Is Neurogene stock public?
Yes, Neurogene is a publicly traded company. -
What is the Neurogene stock quote today?
The Neurogene stock price is 22.34 USD today. -
How to buy Neurogene stock online?
You can buy Neurogene shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Nov-25 | 21.05 | 22.32 | 22.57 | 20.50 |
Nov-26 | 25.97 | 26.87 | 27.61 | 24.23 |
Nov-27 | 27.14 | 25.80 | 27.68 | 24.60 |
Nov-29 | 26.71 | 25.43 | 26.75 | 24.78 |
Dec-2 | 25.20 | 24.57 | 25.93 | 24.49 |
Dec-3 | 24.21 | 22.34 | 24.39 | 22.03 |
Dec-4 | 22.25 | 22.02 | 22.25 | 20.82 |
Dec-5 | 22.04 | 21.99 | 22.59 | 21.44 |
Dec-6 | 22.38 | 23.72 | 24.17 | 21.49 |
Dec-9 | 23.94 | 23.31 | 25.53 | 23.00 |
Dec-10 | 23.26 | 23.70 | 25.11 | 22.99 |
Dec-11 | 24.17 | 23.20 | 24.20 | 22.59 |
Dec-12 | 22.92 | 22.34 | 24.06 | 21.68 |
Dec-13 | 22.44 | 23.51 | 24.37 | 21.85 |
Neurogene Earnings
Neurogene Earnings Report: Per Share Neurogene Earnings Q1 Q2 Q3 and Q4 last year and next year.
Neurogene Forecast Revenue Growth
Neurogene Stock Analysis: Historical quarterly revenues per share for Neurogene and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.04 per share.
* Neurogene stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.